Acute Ischemic Stroke |
| Different Strokes:Addressing Real Clinician Questions and Controversies Surrounding Acute Management of Ischemic Stroke |
Alzheimer's Disease |
| Understanding the Fine PrintThe Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease |
| From the Ground UpEvolving Strategies for the Identification and Team-Based Management of Patients with Early-Stage Alzheimer's Disease Neurobiology |
| From Critique to ConsensusQuantifying & Clarifying Expert Perspectives on the Future Management of Alzheimer's Disease |
| Why Now?The New Paradigm and Rising Role of Nuclear Medicine in Alzheimer’s Disease |
Epilepsy |
| Are We There Yet?New Agents and Foundational Shifts Toward Precision Medicine in Epilepsy |
| The Path of Least ResistanceNew Agents and Emerging Strategies for Managing Childhood-Onset and Refractory Epilepsies |
Idiopathic Hypersomnia and Narcolepsy |
| Hidden in Plan SightExpert Strategies for Eliciting a History of and Effectively Managing Cataplexy in Patients with Narcolepsy Type-1 |
| "Wake Up" - An Adaptation of a Virtual Grand Rounds SeriesModern Strategies to Recognize and Combat Sleepiness in Narcolepsy and Idiopathic Hypersomnia |
Major Depressive Disorder |
| Finding Something in NothingPatient-Centered Approaches to Resolve Emotional Blunting in Major Depressive Disorder |
Migraine |
| Conversations in NeurologyNew Agents And Strategies For Migraine and Related Headache Disorders Edition |
| Networks in NeurologyNew Agents and Strategies for Migraine |
Multiple Sclerosis |
| Overburdened, UndertreatedDevelopments in the Patient-Centered Management of Spasticity in Multiple Sclerosis |
| Battle of the Biomarkers: Assessing Key Factors in Prognosis, Monitoring, and Therapeutic Decision-Making for Disease Worsening in Multiple Sclerosis |
| How Do I...?An Integrated CME Activity Comparing the Clinical Decisions of MS Specialists and General Neurologists |
| Networks in NeurologyExpert Approaches to New Agents and Strategies for MS |
| Calibrating COVIDThe Interplay of Disease Modifying Therapy and Vaccination in Patients with MS |
| Multiple Sclerosis ManagementShedding Light on the Patient Perspective - A CMSC Satellite Symposium |
| Devil in the DetailsAn Expert Guide to Modern Multiple Sclerosis Practices |
| What Can Biomarkers Tell Us?Modern Tools to Assist Navigating Prognosis, Monitoring, and Therapeutic Decision-Making in the Long-Term Management of Multiple Sclerosis |
| Over-Impacted, Under-RepresentedAddressing Health Disparities in Multiple Sclerosis |
| Evolution of Progression:An Expert Forum on Advancements in Monitoring and Treating Multiple Sclerosis |
Myasthenia Gravis |
| Inside Myasthenia GravisWhere Providers and Patients Diverge on Defining Treatment Success |
Neuromyelitis Optica Spectrum Disorder |
| Deciphering Neuromyelitis Optica Spectrum DisorderAddressing Real Clinician Questions Concerning Diagnosis and Management |
| A Deeper Look at Neuromyelitis Optica Spectrum Disorder:A Glimpse Onto the Clinic Floor with Specialists |
| Reshaping the ParadigmAn ACTRIMS-ECTRIMS Satellite Symposium |
| Critical and ContestedA High-Yield Educational Activity Addressing Difficult and Valuable Topics in Neuromyelitis Optica Spectrum Disorders |
Parkinson's Disease |
| On Target with “OFF” Therapies:An Exploration of New Agents and Strategies for Parkinson’s Disease |
| The Next LevelIncorporating Device-Aided Therapies into Parkinson’s Disease Management |
Pompe Disease |
| The Survival EraEvolving Strategies for the Care of Patients with Pompe Disease |
Spasticity and Dystonia |
| Unlocking MovementAddressing Key Challenges and Strategic Solutions in the Use of Botulinum Toxin for Spasticity and Dystonia |
Spinal Muscular Atrophy |
| The New Picture of Spinal Muscular AtrophyTesting, Treatments, and Transitions |